Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

AbTis Defeats Ajinomoto in U.S. Patent Trial

Domestic biotech company AbTis has won a U.S. patent dispute with a Japanese company.AbTis announced on August 14 that it won the Inter Partes Review (IPR) filed by Japan’s Ajinomoto at the U.S.

  • U.S. biotech firm AbTis wins patent dispute against Ajinomoto on August 14.
  • PTAB maintains AbTis' core ADC platform technology patent, AbClick.
  • Ajinomoto's invalidation claims dismissed due to patent law violations.

Celltrion Vegzelma Matches Original Drug in Study

The anticancer drug ‘Vegzelma (ingredient name bevacizumab)’ developed by Celltrion objectively proved its pharmacokinetic equivalence to the original drug through research results analyzing…

  • Vegzelma matches original drug in pharmacokinetic study.
  • Research integrates data from 834 subjects across trials.
  • Celltrion plans to use findings for clinical competitiveness.

More from Friday 14 August →